Literature DB >> 20397265

Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection.

Oleg Heizmann1, Georgios Meimarakis, Andreas Volk, Daniel Matz, Daniel Oertli, Rolf J Schauer.   

Abstract

AIM: To characterize the impact of the Pringle maneuver (PM) and ischemic preconditioning (IP) on total blood supply to the liver following hepatectomies.
METHODS: Sixty one consecutive patients who underwent hepatic resection under inflow occlusion were randomized either to receive PM alone (n = 31) or IP (10 min of ischemia followed by 10 min of reperfusion) prior to PM (n = 30). Quantification of liver perfusion was measured by Doppler probes at the hepatic artery and portal vein at various time points after reperfusion of remnant livers.
RESULTS: Occlusion times of 33 +/- 12 min (mean +/- SD) and 34 +/- 14 min and the extent of resected liver tissue (2.7 segments) were similar in both groups. In controls (PM), on reperfusion of liver remnants for 15 min, portal perfusion markedly decreased by 29% while there was a slight increase of 8% in the arterial blood flow. In contrast, following IP + PM the portal vein flow remained unchanged during reperfusion and a significantly increased arterial blood flow (+56% vs baseline) was observed. In accordance with a better postischemic blood supply of the liver, hepatocellular injury, as measured by alanine aminotransferase (ALT) levels on day 1 was considerably lower in group B compared to group A (247 +/- 210 U/I vs 550 +/- 650 U/I, P < 0.05). Additionally, ALT levels were significantly correlated to the hepatic artery inflow.
CONCLUSION: IP prevents postischemic flow reduction of the portal vein and simultaneously increases arterial perfusion, suggesting that improved hepatic macrocirculation is a protective mechanism following hepatectomy.

Entities:  

Keywords:  Ischemic preconditioning; Liver; Liver blood flow; Reperfusion injury; Surgery

Mesh:

Year:  2010        PMID: 20397265      PMCID: PMC2856828          DOI: 10.3748/wjg.v16.i15.1871

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 2.  New insights into the regulation of hepatic blood flow after ischemia and reperfusion.

Authors:  Benedikt H J Pannen
Journal:  Anesth Analg       Date:  2002-06       Impact factor: 5.108

3.  Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation.

Authors:  Gero Puhl; Klaus-D Schaser; Daniel Pust; Katrin Köhler; Brigitte Vollmar; Michael D Menger; Peter Neuhaus; Utz Settmacher
Journal:  Liver Transpl       Date:  2005-05       Impact factor: 5.799

4.  Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome.

Authors:  Anthony J Demetris; Dympna M Kelly; Bijan Eghtesad; Paulo Fontes; J Wallis Marsh; Kusum Tom; Heinke P Tan; Thomas Shaw-Stiffel; Linda Boig; Paula Novelli; Raymond Planinsic; John J Fung; Amadeo Marcos
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

5.  Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway.

Authors:  S S Yadav; D Sindram; D K Perry; P A Clavien
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

6.  Microcirculatory failure determines lethal hepatocyte injury in ischemic/reperfused rat livers.

Authors:  K Chun; J Zhang; J Biewer; D Ferguson; M G Clemens
Journal:  Shock       Date:  1994-01       Impact factor: 3.454

7.  Continuous versus intermittent portal triad clamping for liver resection: a controlled study.

Authors:  J Belghiti; R Noun; R Malafosse; P Jagot; A Sauvanet; F Pierangeli; J Marty; O Farges
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

8.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

Authors:  R J Ploeg; A M D'Alessandro; S J Knechtle; M D Stegall; J D Pirsch; R M Hoffmann; T Sasaki; H W Sollinger; F O Belzer; M Kalayoglu
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

10.  Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia.

Authors:  Rolf J Schauer; Alexander L Gerbes; Daniel Vonier; Herbert Meissner; Patrick Michl; Rosemarie Leiderer; Friedrich W Schildberg; Konrad Messmer; Manfred Bilzer
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

View more
  4 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 2.  The Delay Phenomenon: A Compilation of Knowledge across Specialties.

Authors:  Kristy Hamilton; Erik M Wolfswinkel; William M Weathers; Amy S Xue; Daniel A Hatef; Shayan Izaddoost; Larry H Hollier
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-02-21

3.  A prospective randomized controlled trial to compare pringle manoeuvre with hemi-hepatic vascular inflow occlusion in liver resection for hepatocellular carcinoma with cirrhosis.

Authors:  Jun-sheng Ni; Wan Yee Lau; Yuan Yang; Ze-Ya Pan; Zhen-guang Wang; Hui Liu; Meng-chao Wu; Wei-ping Zhou
Journal:  J Gastrointest Surg       Date:  2013-05-29       Impact factor: 3.452

Review 4.  Hepatic ischemia and reperfusion injury and trauma: current concepts.

Authors:  Dimitrios Papadopoulos; Thomas Siempis; Eleni Theodorakou; Georgios Tsoulfas
Journal:  Arch Trauma Res       Date:  2013-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.